Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tralokinumab therapy for moderate‐to‐severe atopic dermatitis: Clinical outcomes with targeted IL‐13 inhibition
Eric L. Simpson, Emma Guttman‐Yassky, Lawrence F. Eichenfield, et al.
Allergy (2023) Vol. 78, Iss. 11, pp. 2875-2891
Open Access | Times Cited: 10

Showing 10 citing articles:

The Interplay of Nutrition, the Gut Microbiota and Immunity and Its Contribution to Human Disease
Samantha L. Dawson, Emma Todd, Alister C. Ward
Biomedicines (2025) Vol. 13, Iss. 2, pp. 329-329
Open Access | Times Cited: 1
Infections in Patients with Atopic Dermatitis and the Influence of Treatment
Maddalena Napolitano, Maria Esposito, Maria Concetta Fargnoli, et al.
American Journal of Clinical Dermatology (2025)
Open Access | Times Cited: 1
Real-World Effectiveness and Safety of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis: A 16-Week Study in Japan
Teppei Hagino, Akihiko Uchiyama, Marina Onda, et al.
Dermatitis (2025)
Closed Access | Times Cited: 1
Emerging Systemic Treatment Options in Atopic Dermatitis
Andaç Salman, Ana M. Giménez‐Arnau
Balkan Medical Journal (2024), pp. 239-247
Open Access | Times Cited: 4
Long-Term Disease Control and Minimal Disease Activity of Head and Neck Atopic Dermatitis in Patients Treated with Tralokinumab up to 4 Years
Raj Chovatiya, Simone Ribero, Andreas Wollenberg, et al.
American Journal of Clinical Dermatology (2025)
Open Access
Type 2 Inflammation and Its Role in Dermatologic Diseases
Raj Chovatiya, Jason E. Hawkes, Douglas DiRuggiero, et al.
International Journal of Dermatology (2025)
Open Access
IL-13 inhibition in the treatment of atopic dermatitis – new and emerging biologic agents
Carlos Eduardo Garcez Teixeira, Orhan Yilmaz, Diana Bernardo, et al.
Journal of International Medical Research (2024) Vol. 52, Iss. 11
Open Access | Times Cited: 3
Atopic dermatitis: pathogenesis and therapeutic intervention
Chengcheng Yue, Hong Zhou, Xiaoyan Wang, et al.
MedComm (2024) Vol. 5, Iss. 12
Closed Access | Times Cited: 2
Current and Emerging Biologics for Atopic Dermatitis
Michael Z. Nevid, Mark Boguniewicz
Immunology and Allergy Clinics of North America (2024) Vol. 44, Iss. 4, pp. 577-594
Closed Access | Times Cited: 1
A critical evaluation of suitability of tralokinumab for treatment of moderate-to-severe atopic dermatitis in adolescents and adults
Elena Pezzolo, Andrea Sechi, Jacopo Tartaglia, et al.
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 3, pp. 255-266
Closed Access | Times Cited: 2
Page 1

Scroll to top